Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Clin Case Rep ; 11(12): e8283, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38076012

RESUMEN

Key Clinical Message: Tumor-induced osteomalacia is a paraneoplastic syndrome characterized by renal phosphate wasting and deranged bone turnover. Clinicians should consider tumor-induced osteomalacia in unexplained hypophosphatemia and investigate for underlying tumors. Abstract: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by renal phosphate wasting, which leads to deranged bone turnover. TIO is usually associated with benign mesenchymal tumors, although it has also been reported in malignant tumors. We present the case of a 56-year-old individual who experienced a protracted 6-year clinical course characterized by hypophosphatemia, weakness, and kyphosis, alongside the presence of a foot tumor. Subsequently, this lesion displayed malignant behavior and was ultimately diagnosed as a high-grade sarcoma. To date, this case is among the 10 reported cases in the literature of a mesenchymal tumor associated with TIO undergoing malignant transformation. This report underscores the importance of a comprehensive evaluation of patients with unexplained hypophosphatemia and highlights the need for diligent follow-up to detect possible malignant transformation of the underlying tumor. Clinicians should consider TIO in the differential diagnosis of hypophosphatemia and promptly investigate for the presence of an underlying tumor, as early detection may improve the patient's prognosis.

2.
Clin Case Rep ; 11(11): e8100, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37900716

RESUMEN

Key Clinical Message: The detection of a novel HMBS gene mutation (c.457C > T) in a Mexican woman with acute intermittent porphyria underscores the importance of expanding genetic analyses in diverse populations to improve diagnosis, management, and knowledge of the disease's clinical implications. Abstract: Acute intermittent porphyria (AIP) is an autosomal dominant disorder caused by a deficiency in the enzymatic activity of porphobilinogen deaminase (HMBS), resulting in the accumulation of toxic heme metabolites. In this report, we present the case of a Mexican woman with AIP who experienced recurrent episodes of severe abdominal pain, weakness, vomiting, and insomnia. Despite the challenges in diagnosis and treatment, genetic analysis revealed a novel HMBS mutation, c.457C > T (p.Q153X), located in exon 9. This mutation induces a premature translational stop codon and had not been previously reported in medical literature among individuals with AIP. Remarkably, the patient exhibited a positive response to RNA interference therapy. We hypothesize that this novel HMBS mutation may potentially account for the more severe clinical presentation observed in this case. However, further research is necessary to establish a definitive link between this specific mutation and disease severity. The prevalence and genetic variants of AIP in Mexico remain largely unknown, underscoring the importance of conducting additional research and expanding genetic analyses to gain a better understanding of the clinical implications associated with these mutations.

3.
Case Rep Infect Dis ; 2022: 3348393, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35273815

RESUMEN

Hemophagocytic lymphohistiocytosis (HLH) is characterized by a dysregulated activation of the immune system that causes fever, cytopenias, organomegalies, and hemophagocytosis. There are infectious, neoplastic, rheumatologic, and miscellaneous causes. Rickettsioses are a neglected cause of HLH. We report a confirmed case of an immunocompetent woman in Mexico with postpartum HLH secondary to spotted fever. We did a review of the literature for search of similar cases. The association between these two diseases was found in postmortem studies, unrelated to postpartum. This diagnosis should be considered in all patients with HLH without an evident cause in areas of epidemiological risk.

4.
Case Rep Neurol Med ; 2020: 7956350, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32670647

RESUMEN

Sarcoidosis is a multisystemic inflammatory disease of unknown cause. It is characterized by the presence of noncaseating granuloma on a biopsy specimen. Clinical presentation varies across case report series with myriad of symptoms ranging from fever, respiratory symptoms, and skin lesions, or atypical symptoms like heart block or neurological symptoms. Hence, we report the case of a 22-year-old woman with encephalitis, a pituitary mass, and adipsic diabetes insipidus. The diagnostic approach did not end on the biopsy of the lesion, which reported noncaseating granulomas; on the contrary, it was the beginning of a path to exclude other causes of the central nervous system granulomas that ended with the diagnosis of the isolated central nervous system sarcoidosis. Also, we report the first proven association between anti-NMDA receptor antibodies and sarcoidosis.

5.
Arch Med Res ; 46(8): 651-8, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26696552

RESUMEN

BACKGROUND AND AIMS: Severe influenza A(H1N1)pdm2009 virus infection cases are characterized by sustained immune activation during influenza pandemics. Seasonal flu data suggest that immune mediators could be modified by wave-related changes. Our aim was to determine the behavior of soluble and cell-related mediators in two waves at the epicenter of the 2009 influenza pandemic. METHODS: Leukocyte surface activation markers were studied in serum from peripheral blood samples, collected from the 1(st) (April-May, 2009) and 2(nd) (October 2009-February 2010) pandemic waves. Patients with confirmed influenza A(H1N1)pdm2009 virus infection (H1N1), influenza-like illness (ILI) or healthy donors (H) were analyzed. RESULTS: Serum IL-6, IL-4 and IL-10 levels were elevated in H1N1 patients from the 2(nd) pandemic wave. Additionally, the frequency of helper and cytotoxic T cells was reduced during the 1(st) wave, whereas CD69 expression in helper T cells was increased in the 2(nd) wave for both H1N1 and ILI patients. In contrast, CD62L expression in granulocytes from the ILI group was increased in both waves but in monocytes only in the 2(nd) wave. Triggering Receptor Expressed on Myeloid cells (TREM)-1 expression was elevated only in H1N1 patients at the 1(st) wave. CONCLUSIONS: Our results show that during the 2009 influenza pandemic a T cell activation phenotype is observed in a wave-dependent fashion, with an expanded activation in the 2(nd) wave, compared to the 1(st) wave. Conversely, granulocyte and monocyte activation is infection-dependent. This evidence collected at the pandemic epicenter in 2009 could help us understand the differences in the underlying cellular mechanisms that drive the wave-related immune profile behaviors that occur against influenza viruses during pandemics.


Asunto(s)
Subtipo H1N1 del Virus de la Influenza A/inmunología , Gripe Humana/inmunología , Interleucina-10/sangre , Interleucina-4/sangre , Interleucina-6/sangre , Linfocitos T Citotóxicos/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Adolescente , Adulto , Anciano , Antígenos CD/biosíntesis , Antígenos de Diferenciación de Linfocitos T/biosíntesis , Biomarcadores , Recuento de Linfocito CD4 , Femenino , Humanos , Gripe Humana/virología , Interleucina-10/inmunología , Interleucina-4/inmunología , Interleucina-6/inmunología , Selectina L/biosíntesis , Lectinas Tipo C/biosíntesis , Activación de Linfocitos/inmunología , Masculino , Glicoproteínas de Membrana/biosíntesis , Persona de Mediana Edad , Monocitos/inmunología , Neutrófilos/inmunología , Pandemias , Receptores Inmunológicos/biosíntesis , Receptor Activador Expresado en Células Mieloides 1 , Adulto Joven
6.
World J Gastroenterol ; 20(32): 11443-50, 2014 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-25170234

RESUMEN

Intestinal pseudo-obstruction secondary to systemic lupus erythematosus (SLE) is a rare syndrome described in recent decades. There are slightly over 30 published cases in the English language literature, primarily associated with renal and hematological disease activity. Its presentation and evolution are a diagnostic challenge for the clinician. We present four cases of intestinal pseudo-obstruction due to lupus in young Mexican females. One patient had a previous diagnosis of SLE and all presented with a urinary tract infection of varying degrees of severity during their evolution. We consider that recognition of the disease is of vital importance because it allows for establishing appropriate management, leading to a better prognosis and avoiding unnecessary surgery and complications.


Asunto(s)
Seudoobstrucción Intestinal/etiología , Lupus Eritematoso Sistémico/complicaciones , Adulto , Antibacterianos/uso terapéutico , Femenino , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Inmunosupresores/uso terapéutico , Seudoobstrucción Intestinal/diagnóstico , Seudoobstrucción Intestinal/terapia , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/terapia , México , Nutrición Parenteral Total , Esteroides/uso terapéutico , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Infecciones Urinarias/diagnóstico , Infecciones Urinarias/etiología , Adulto Joven
7.
Gac. méd. Méx ; 135(3): 235-8, mayo-jun. 1999. tab, ilus
Artículo en Español | LILACS | ID: lil-266423

RESUMEN

La infección por larva migrans cutánea se presenta habitualmente como una erupción dérmica serpenginosa y pruriginosa debida a la penetración de la piel en túnel por larvas de nematelmintos. Esta parasitosis es endémica en zona tropicales, sin embargo se describen cada vez más casos en zonas urbanas. El diagnóstico de esta entidad es clínico, pero es frecuente que se confunda con enfermedades reumatológicas, infecciosas, vasculares o dermatológicas; especialmente cuando su presentación es como eritema migratorio. En este trabajo se revisa la presentación clínica y el tratamiento de 18 casos con infección por larva migrans cutánea


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Diagnóstico Clínico , Enfermedades Cutáneas Parasitarias/diagnóstico , Enfermedades Cutáneas Parasitarias/terapia , Larva Migrans/diagnóstico , Larva Migrans/terapia , Albendazol/administración & dosificación , Albendazol/uso terapéutico , Ivermectina/administración & dosificación , Ivermectina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA